Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune(R) Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization

EAST HANOVER, N.J., Nov. 24, 2023 -- (Healthcare Sales & Marketing Network) -- Novartis is conducting a voluntary nationwide recall at the consumer level of two lots of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the ... Biopharmaceuticals, Product Recall Novartis, Sandimmune, cyclosporine, organ transplant
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news